These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 17680579)

  • 1. Design, synthesis, and pharmacological evaluation of mefloquine-based ligands as novel antituberculosis agents.
    Mao J; Wang Y; Wan B; Kozikowski AP; Franzblau SG
    ChemMedChem; 2007 Nov; 2(11):1624-30. PubMed ID: 17680579
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structure-activity relationships for a series of quinoline-based compounds active against replicating and nonreplicating Mycobacterium tuberculosis.
    Lilienkampf A; Mao J; Wan B; Wang Y; Franzblau SG; Kozikowski AP
    J Med Chem; 2009 Apr; 52(7):2109-18. PubMed ID: 19271749
    [TBL] [Abstract][Full Text] [Related]  

  • 3. From serendipity to rational antituberculosis drug discovery of mefloquine-isoxazole carboxylic acid esters.
    Mao J; Yuan H; Wang Y; Wan B; Pieroni M; Huang Q; van Breemen RB; Kozikowski AP; Franzblau SG
    J Med Chem; 2009 Nov; 52(22):6966-78. PubMed ID: 19863050
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification, synthesis, and pharmacological evaluation of tetrahydroindazole based ligands as novel antituberculosis agents.
    Guo S; Song Y; Huang Q; Yuan H; Wan B; Wang Y; He R; Beconi MG; Franzblau SG; Kozikowski AP
    J Med Chem; 2010 Jan; 53(2):649-59. PubMed ID: 20000470
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and antituberculosis activity of novel mefloquine-isoxazole carboxylic esters as prodrugs.
    Mao J; Yuan H; Wang Y; Wan B; Pak D; He R; Franzblau SG
    Bioorg Med Chem Lett; 2010 Feb; 20(3):1263-8. PubMed ID: 20022500
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rational design of 5-phenyl-3-isoxazolecarboxylic acid ethyl esters as growth inhibitors of Mycobacterium tuberculosis. a potent and selective series for further drug development.
    Lilienkampf A; Pieroni M; Wan B; Wang Y; Franzblau SG; Kozikowski AP
    J Med Chem; 2010 Jan; 53(2):678-88. PubMed ID: 20000577
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design, synthesis, and SAR studies of mefloquine-based ligands as potential antituberculosis agents.
    Jayaprakash S; Iso Y; Wan B; Franzblau SG; Kozikowski AP
    ChemMedChem; 2006 Jun; 1(6):593-7. PubMed ID: 16892398
    [No Abstract]   [Full Text] [Related]  

  • 8. Design, synthesis and investigation on the structure-activity relationships of N-substituted 2-aminothiazole derivatives as antitubercular agents.
    Pieroni M; Wan B; Cho S; Franzblau SG; Costantino G
    Eur J Med Chem; 2014 Jan; 72():26-34. PubMed ID: 24333612
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis, biological evaluation, and structure-activity relationships for 5-[(E)-2-arylethenyl]-3-isoxazolecarboxylic acid alkyl ester derivatives as valuable antitubercular chemotypes.
    Pieroni M; Lilienkampf A; Wan B; Wang Y; Franzblau SG; Kozikowski AP
    J Med Chem; 2009 Oct; 52(20):6287-96. PubMed ID: 19757815
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HTS, chemical hybridization, and drug design identify a chemically unique antituberculosis agent-coupling serendipity and rational approaches to drug discovery.
    Mao J; Wan B; Wang Y; Franzblau SG; Kozikowski AP
    ChemMedChem; 2007 Jun; 2(6):811-3. PubMed ID: 17455191
    [No Abstract]   [Full Text] [Related]  

  • 11. 2,3-dideoxy hex-2-enopyranosid-4-uloses as promising new anti-tubercular agents: design, synthesis, biological evaluation and SAR studies.
    Saquib M; Husain I; Sharma S; Yadav G; Singh VK; Sharma SK; Shah P; Siddiqi MI; Kumar B; Lal J; Jain GK; Srivastava BS; Srivastava R; Shaw AK
    Eur J Med Chem; 2011 Jun; 46(6):2217-23. PubMed ID: 21440336
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and characterization of novel hydrazide-hydrazones and the study of their structure-antituberculosis activity.
    Bedia KK; Elçin O; Seda U; Fatma K; Nathaly S; Sevim R; Dimoglo A
    Eur J Med Chem; 2006 Nov; 41(11):1253-61. PubMed ID: 16919372
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and antitubercular activity of new mefloquine-oxazolidine derivatives.
    Gonçalves RS; Kaiser CR; Lourenço MC; de Souza MV; Wardell JL; Wardell SM; da Silva AD
    Eur J Med Chem; 2010 Dec; 45(12):6095-100. PubMed ID: 20932608
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antitubercular activities of novel benzothiazolo naphthyridone carboxylic acid derivatives endowed with high activity toward multi-drug resistant tuberculosis.
    Dinakaran M; Senthilkumar P; Yogeeswari P; Sriram D
    Biomed Pharmacother; 2009 Jan; 63(1):11-8. PubMed ID: 18078735
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Schiff bases of indoline-2,3-dione (isatin) derivatives and nalidixic acid carbohydrazide, synthesis, antitubercular activity and pharmacophoric model building.
    Aboul-Fadl T; Bin-Jubair FA; Aboul-Wafa O
    Eur J Med Chem; 2010 Oct; 45(10):4578-86. PubMed ID: 20696500
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preliminary structure-activity relationships and biological evaluation of novel antitubercular indolecarboxamide derivatives against drug-susceptible and drug-resistant Mycobacterium tuberculosis strains.
    Onajole OK; Pieroni M; Tipparaju SK; Lun S; Stec J; Chen G; Gunosewoyo H; Guo H; Ammerman NC; Bishai WR; Kozikowski AP
    J Med Chem; 2013 May; 56(10):4093-103. PubMed ID: 23611124
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis, biological evaluation, and SAR study of novel pyrazole analogues as inhibitors of Mycobacterium tuberculosis: part 2. Synthesis of rigid pyrazolones.
    Castagnolo D; Manetti F; Radi M; Bechi B; Pagano M; De Logu A; Meleddu R; Saddi M; Botta M
    Bioorg Med Chem; 2009 Aug; 17(15):5716-21. PubMed ID: 19581099
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and evaluation of rifabutin analogs against Mycobacterium avium and H(37)Rv, MDR and NRP Mycobacterium tuberculosis.
    Figueiredo R; Moiteiro C; Medeiros MA; da Silva PA; Ramos D; Spies F; Ribeiro MO; Lourenço MC; Júnior IN; Gaspar MM; Cruz ME; Curto MJ; Franzblau SG; Orozco H; Aguilar D; Hernandez-Pando R; Costa MC
    Bioorg Med Chem; 2009 Jan; 17(2):503-11. PubMed ID: 19119013
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Searching for new cures for tuberculosis: design, synthesis, and biological evaluation of 2-methylbenzothiazoles.
    Huang Q; Mao J; Wan B; Wang Y; Brun R; Franzblau SG; Kozikowski AP
    J Med Chem; 2009 Nov; 52(21):6757-67. PubMed ID: 19817445
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design, synthesis, and biological evaluation of new cinnamic derivatives as antituberculosis agents.
    De P; Koumba Yoya G; Constant P; Bedos-Belval F; Duran H; Saffon N; Daffé M; Baltas M
    J Med Chem; 2011 Mar; 54(5):1449-61. PubMed ID: 21309577
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.